Fluorescent benzofuran histamine H3 receptor antagonists with sub-nanomolar potency

Inflammation Research

Volumn 55, Issue SUPPL. 1, 2006, Pages

  Cowart, M ^a   Gfesser, G A ^a   Bhatia, K ^a   Esser, R ^a   Sun, M ^a   Miller, T R ^a   Krueger, K ^a   Witte, D ^a   Esbenshade, T A ^a   Hancock, A A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOFURAN DERIVATIVE; DANSYL CHLORIDE; DIMETHYLAMINOBENZODIOXAZOL 4 YL DERIVATIVE; G PROTEIN COUPLED RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; NITROBENZODIOXAZOL 4 YL DERIVATIVE; TETRAMETHYLRHODAMINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG POTENCY; FLUORESCENCE; HUMAN; LIPOPHILICITY; NONHUMAN; RECEPTOR OCCUPANCY; STRUCTURE ACTIVITY RELATION;

BENZOFURANS; FLUORESCENCE; HISTAMINE ANTAGONISTS; LIGANDS; RECEPTORS, HISTAMINE H3;

EID: 33646773584     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-0036-y     Document Type: Conference Paper

References (8)

1. Daly, CJ, McGrath JC. Fluorescent ligands, antibodies, and proteins for the study of receptors. Pharmacol Ther 2003; 100: 101-18.
2. th ed. Molecular Probes, 1992.
3. rd Annual Meeting of the European Histamine Research Society, April 28-May 2, 2004; Dusseldorf, Germany.
4. 1 Receptor Antagonists Related to Mepyramine. Bioorg Med Chem Lett 2003; 13: 1245-8.
5. 2 receptor: Synthesis and Preliminary Characterization. Bioorg Med Chem Lett 2004; 12, 6495-503.
6. 3 Receptor Antagonists Potently Enhance Cognition and Attention. J Med Chem 2005; 48: 38-45.
7. Cowart MD, Bennani YL, Faghih R, Gfesser GA, Black LA. Novel histamine H, receptor igands and their therapeutic applications. US2002/0169188A1.
8. 3 Receptor Antagonist with Drug-Like Properties. J Pharmacol Exp Ther 2005; 313: 165-75.